Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Graham G. Walmsley Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 4 Graham G. Walmsley (Director) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Bought 25,000 shares @ $42.059, valued at $1.1M
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/23/2023 4 Graham G. Walmsley (Director) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Bought 400,000 shares @ $26, valued at $10.4M
Bought 120,000 shares @ $42, valued at $5M
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/15/2020 4 Graham G. Walmsley (Director) has filed a Form 4 on ALX ONCOLOGY HOLDINGS INC
Txns: Bought 20,000 shares @ $76, valued at $1.5M
11/23/2020 4 Graham G. Walmsley (Director) has filed a Form 4 on Olema Pharmaceuticals, Inc.
Txns: Converted 1,400,761 shares @ $0
Converted 1,183,114 shares @ $0
Bought 1,160,000 shares @ $19, valued at $22M
Converted 1,400,761 convertible preferred @ $0
Converted 1,183,114 convertible preferred @ $0
11/19/2020 4 Graham G. Walmsley (Director) has filed a Form 4 on Olema Pharmaceuticals, Inc.
Txns: Bought 339,578 convertible preferred @ $4.7117, valued at $1.6M
Bought 1,183,114 convertible preferred @ $11.0623, valued at $13.1M
Granted 21,520 options to buy @ $19, valued at $408.9k
07/21/2020 4 Graham G. Walmsley (Director) has filed a Form 4 on ALX ONCOLOGY HOLDINGS INC
Txns: Converted 2,105,901 shares @ $0
Bought 975,000 shares @ $19, valued at $18.5M
Converted 2,105,901 convertible preferred @ $0
07/17/2020 4 Graham G. Walmsley (Director) has filed a Form 4 on ALX ONCOLOGY HOLDINGS INC
Txns: Granted 24,009 options to buy @ $19, valued at $456.2k
06/02/2020 4 Graham G. Walmsley (Director) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Granted 13,000 options to buy @ $25.2, valued at $327.6k
04/01/2020 4 Graham G. Walmsley (Director) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Exercised 2,168 shares @ $19.97, valued at $43.3k
Exercised 2,168 options to buy @ $19.97, valued at $43.3k
11/12/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy